AlphaStocks
4.3
Weak

STRYKER CORP (SYK)

Health Care / Health Care Equipment

S&P 500

$291.03

Below average on several measures. Research carefully.

Weak

Score based on 5 of 5 models — high confidence

#773out of 1126 in Health Care

Is STRYKER CORP a Good Investment in 2026?

STRYKER CORP (SYK) scores 4.3 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates STRYKER CORP as Attractive (6/9). However, the Graham model rates it Caution — Significantly above fair value. STRYKER CORP currently trades below its estimated fair value of $367, suggesting potential upside. STRYKER CORP ranks #773 out of 1126 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E23.0ROE22.1Market Cap111BDiv Yield1.1

Estimated Fair Value

$366.6421% below

Fair value above market price. EPS grew 32% year-over-year. ROE of 22% signals strong profitability. P/E of 23x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Attractive

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Neutral

PEG 2.9 · Stalwart

Greenblatt

Attractive

Top 25% (rank 15%)

Frequently Asked Questions

Is STRYKER CORP (SYK) a good investment?
Based on AlphaStocks' composite analysis, STRYKER CORP (SYK) scores 4.3 out of 10, earning a Weak rating. This score is below average, suggesting caution. Fair value above market price. EPS grew 32% year-over-year. ROE of 22% signals strong profitability. P/E of 23x is moderate for this quality level.
What is STRYKER CORP's Piotroski F-Score?
STRYKER CORP's Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is SYK overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $367, SYK appears undervalued. The stock currently trades 21% below its estimated fair value. Fair value above market price. EPS grew 32% year-over-year. ROE of 22% signals strong profitability. P/E of 23x is moderate for this quality level.
How does SYK compare to other Health Care stocks?
STRYKER CORP ranks #773 out of 1126 stocks in the Health Care sector, placing it in the top 69% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about SYK?
AlphaStocks evaluates SYK using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 4.3/10.

Similar Stocks

PARRFTIAZN

Compare SYK with

SYK vs PARRSYK vs FTISYK vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer